Home › Funds › Fortress Investment Group LLC › RNA

Fortress Investment Group LLC position in RNA

ATRIUM THERAPEUTICS INC · Health Care

Fortress Investment Group LLC reported holding 20,000 shares of RNA (ATRIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$166K, representing 0.03% of its reported portfolio and ranking #24 among its reported holdings. Fortress Investment Group LLC has disclosed RNA holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)20.00K sh
Reported value held$165.60K
Portfolio Weight0.03%
First reportedQ1 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Fortress Investment Group LLC's RNA position evolved

Fortress Investment Group LLC first disclosed a stake in RNA in Q1 2026 at 22,033 shares (US$295K). Across 2 filings, Fortress Investment Group LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 20,000 shares valued at US$166K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 22.03K $294.58K New
Q3 2026 20.00K $165.60K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RNA and 13F data

RNA (ATRIUM THERAPEUTICS INC) is a Health Care company. 88 other funds we track also report a position in RNA — the largest reported positions include Sessa Capital IM, L.P. (US$20.2M), TIG Advisors, LLC (US$7.6M), O'Connor Alternative Investments LLC (US$4.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RNA

All RNA fund holders →

FAQ

How long has Fortress Investment Group LLC held RNA?

Fortress Investment Group LLC has disclosed RNA holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

What is Fortress Investment Group LLC's current position in RNA?

As of Q3 2026, Fortress Investment Group LLC holds 20.00K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $165.60K, representing 0.03% of its reported portfolio and ranking #24.

Has Fortress Investment Group LLC been buying or selling RNA?

In the latest 13F filing (Q3 2026), Fortress Investment Group LLC newly opened its position in RNA.

Which other funds hold RNA?

Other major institutional holders of RNA include Sessa Capital IM, L.P., TIG Advisors, LLC, O'Connor Alternative Investments LLC, among 88 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.